Anushka Patel

Summary

Affiliation: The George Institute for International Health
Country: Australia

Publications

  1. doi request reprint Trials of cardiovascular risk factor management in type 2 diabetes
    Anushka Patel
    George Institute for International Health, University of Sydney, Sydney, New South Wales, Australia
    Curr Opin Cardiol 24:288-94. 2009
  2. ncbi request reprint Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
    Anushka Patel
    Cardiovascular Division, The George Institute for International Health, University of Sydney, PO Box M201, Missenden Road, Sydney, NSW 2050, Australia
    Lancet 370:829-40. 2007
  3. pmc Lowering blood pressure reduces renal events in type 2 diabetes
    Bastiaan E De Galan
    George Institute for International Health, University of Sydney, Sydney, NSW, Australia
    J Am Soc Nephrol 20:883-92. 2009
  4. pmc Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial
    Sophia Zoungas
    The George Institute for International Health, University of Sydney, Sydney, New South Wales, Australia
    Diabetes Care 32:2068-74. 2009
  5. ncbi request reprint New insights from ADVANCE
    John Chalmers
    The George Institute for International Health, University of Sydney and The Royal Prince Alfred Hospital, Sydney, NSW, Australia
    J Hypertens Suppl 25:S23-30. 2007
  6. ncbi request reprint Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial
    Toshiharu Ninomiya
    The George Institute for International Health, University of Sydney, New South Wales, Australia
    J Hypertens 28:1141-9. 2010
  7. ncbi request reprint New insights from ADVANCE
    John Chalmers
    The George Institute for International Health, University of Sydney and The Royal Prince Alfred Hospital, Sydney, NSW, Australia
    J Hypertens Suppl 25:S23-30. 2007
  8. doi request reprint Smoking, diabetes and cardiovascular diseases in men in the Asia Pacific region
    Andre Pascal Kengne
    The George Institute for International Health, The University of Sydney, NSW, Australia
    J Diabetes 1:173-81. 2009
  9. ncbi request reprint Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence
    John Chalmers
    The George Institute for International Health, The University of Sydney and The Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    J Hypertens 26:S23-30. 2008
  10. doi request reprint Severe hypoglycemia and risks of vascular events and death
    Sophia Zoungas
    George Institute for International Health, University of Sydney, Sydney, Australia
    N Engl J Med 363:1410-8. 2010

Collaborators

Detail Information

Publications68

  1. doi request reprint Trials of cardiovascular risk factor management in type 2 diabetes
    Anushka Patel
    George Institute for International Health, University of Sydney, Sydney, New South Wales, Australia
    Curr Opin Cardiol 24:288-94. 2009
    ..To provide an overview of recent clinical trial findings relevant to cardiovascular risk management in patients with diabetes...
  2. ncbi request reprint Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
    Anushka Patel
    Cardiovascular Division, The George Institute for International Health, University of Sydney, PO Box M201, Missenden Road, Sydney, NSW 2050, Australia
    Lancet 370:829-40. 2007
    ....
  3. pmc Lowering blood pressure reduces renal events in type 2 diabetes
    Bastiaan E De Galan
    George Institute for International Health, University of Sydney, Sydney, NSW, Australia
    J Am Soc Nephrol 20:883-92. 2009
    ..We could not identify a BP threshold below which renal benefit is lost...
  4. pmc Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial
    Sophia Zoungas
    The George Institute for International Health, University of Sydney, Sydney, New South Wales, Australia
    Diabetes Care 32:2068-74. 2009
    ..To assess the magnitude and independence of the effects of routine blood pressure lowering and intensive glucose control on clinical outcomes in patients with long-standing type 2 diabetes...
  5. ncbi request reprint New insights from ADVANCE
    John Chalmers
    The George Institute for International Health, University of Sydney and The Royal Prince Alfred Hospital, Sydney, NSW, Australia
    J Hypertens Suppl 25:S23-30. 2007
    ..5% or less reduces these two outcomes compared with standard guidelines therapy; and finally whether the separate benefits of these two treatment regimens are additive...
  6. ncbi request reprint Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial
    Toshiharu Ninomiya
    The George Institute for International Health, University of Sydney, New South Wales, Australia
    J Hypertens 28:1141-9. 2010
    ....
  7. ncbi request reprint New insights from ADVANCE
    John Chalmers
    The George Institute for International Health, University of Sydney and The Royal Prince Alfred Hospital, Sydney, NSW, Australia
    J Hypertens Suppl 25:S23-30. 2007
    ....
  8. doi request reprint Smoking, diabetes and cardiovascular diseases in men in the Asia Pacific region
    Andre Pascal Kengne
    The George Institute for International Health, The University of Sydney, NSW, Australia
    J Diabetes 1:173-81. 2009
    ..To assess whether there is a statistical interaction between smoking and diabetes that is related to the risk of cardiovascular disease (CVD) in men in the Asia Pacific region...
  9. ncbi request reprint Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence
    John Chalmers
    The George Institute for International Health, The University of Sydney and The Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    J Hypertens 26:S23-30. 2008
    ..The results suggest that for every 79 patients treated in this manner, one death would be avoided over 5 years...
  10. doi request reprint Severe hypoglycemia and risks of vascular events and death
    Sophia Zoungas
    George Institute for International Health, University of Sydney, Sydney, Australia
    N Engl J Med 363:1410-8. 2010
    ..We analyzed data from a large study of intensive glucose lowering to explore the relationship between severe hypoglycemia and adverse clinical outcomes...
  11. pmc Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus
    Graham S Hillis
    The George Institute for Global Health, University of Sydney, Australia
    J Am Heart Assoc 1:e002832. 2012
    ..The present study tests the hypothesis that a higher resting heart rate is associated with an increased incidence and a greater progression of microvascular complications in patients with type 2 diabetes mellitus...
  12. doi request reprint Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes
    Susan van Dieren
    The George Institute for Global Health, University of Sydney, Sydney, Australia
    Diabetes Res Clin Pract 98:83-90. 2012
    ..To asses differences in treatment effects of a fixed combination of perindopril-indapamide on major clinical outcomes in patients with type 2 diabetes across subgroups of cardiovascular risk...
  13. doi request reprint Contemporary model for cardiovascular risk prediction in people with type 2 diabetes
    Andre Pascal Kengne
    The George Institute for International Health, The University of Sydney, Australia
    Eur J Cardiovasc Prev Rehabil 18:393-8. 2011
    ..This report presents a contemporary model for predicting cardiovascular risk in people with type 2 diabetes mellitus...
  14. ncbi request reprint ADVANCE: breaking new ground in type 2 diabetes
    John Chalmers
    The George Institute for International Health, The University of Sydney and The Royal Prince Alfred Hospital, Sydney, NSW, Australia
    J Hypertens Suppl 24:S22-8. 2006
    ..5% or less will confer greater protection against microvascular disease; and whether the benefits of the two interventions are additive...
  15. doi request reprint Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
    Vlado Perkovic
    The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia
    Kidney Int 83:517-23. 2013
    ..Thus, improved glucose control will improve major kidney outcomes in patients with type 2 diabetes...
  16. pmc Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial
    Jun Hata
    The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia
    PLoS ONE 8:e55807. 2013
    ..The aim of the present analysis is to assess the effects of the endpoint adjudication process on the main findings of the ADVANCE trial (Trial registration: ClinicalTrials.gov NCT00145925)...
  17. doi request reprint Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice
    Emma Heeley
    The George Institute for Global Health, Royal Prince Alfred Hospital and University of Sydney, Sydney, NSW, Australia
    Int J Stroke 7:649-54. 2012
    ..Extensive evidence exists regarding the effectiveness of secondary prevention measures in patients with cardiovascular disease...
  18. ncbi request reprint ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes
    Vlado Perkovic
    The George Institute for International Health, The University of Sydney, NSW, Australia
    Blood Press 15:340-6. 2006
    ..We describe the experience of participants receiving active blood pressure lowering therapy during the run-in phase of the study, and the characteristics of participants who withdrew during this phase...
  19. ncbi request reprint Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence
    John Chalmers
    The George Institute for International Health, The University of Sydney and The Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    J Hypertens Suppl 26:S21-7. 2008
    ....
  20. doi request reprint Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study
    Xin Du
    The George Institute for International Health, University of Sydney, Level 10, King George V Building, Royal Prince Alfred Hospital, PO Box M201, Missenden Road, Camperdown, Sydney, NSW 2050, Australia
    Eur Heart J 30:1128-35. 2009
    ....
  21. doi request reprint Socio-economic distribution of cardiovascular risk factors and knowledge in rural India
    M Justin Zaman
    Cardiovascular Division, The George Institute for Global Health, University of Sydney, NSW, Australia
    Int J Epidemiol 41:1302-14. 2012
    ..To investigate the prevalence, screening and knowledge of cardiovascular risk factors (CVRFs) by socio-economic position (SEP) in rural India...
  22. doi request reprint Prediction of kidney-related outcomes in patients with type 2 diabetes
    Meg J Jardine
    George Institute For Global Health, Sydney, Australia
    Am J Kidney Dis 60:770-8. 2012
    ..Tools are needed to predict which individuals with diabetes will develop kidney disease and its complications...
  23. pmc Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trial
    Mark Woodward
    The George Institute, University of Sydney, Sydney, Australia
    Diabetes Care 34:2491-5. 2011
    ..We examined whether the effects of intensive glycemic control on major outcomes in ADVANCE differ between participants from Asia, established market economies (EMEs), and eastern Europe...
  24. doi request reprint Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study
    Fiona Turnbull
    The George Institute for Global Health, University of Sydney, New South Wales, Australia
    Eur J Cardiovasc Prev Rehabil 18:498-503. 2011
    ....
  25. doi request reprint Advances in reducing the burden of vascular disease in type 2 diabetes
    John Chalmers
    The George Institute for International Health, The University of Sydney and The Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    Clin Exp Pharmacol Physiol 35:434-7. 2008
    ....
  26. doi request reprint The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
    Sebastien Czernichow
    The George Institute, Sydney, Australia
    J Hypertens 29:4-16. 2011
    ..The objective was to compare the risk reductions achieved by different blood pressure-lowering regimens among individuals with different baseline blood pressures...
  27. doi request reprint Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial
    Jun Hata
    From The George Institute for Global Health, University of Sydney, Sydney, Australia J H, H A, M W, S Z, C A, A P, B N, S M, J C University of Oxford, Oxford, United Kingdom P M R, S M School of Public Health, Monash University, Clayton, Australia S Z Bond University, Gold Coast, Australia P G Université de Montréal, Montreal, Canada P H University of Milan Bicocca, Milan, Italy G M Imperial College, London, United Kingdom N P and University College London UCL and the National Institute for Health Research UCL Hospitals Biomedical Research Centre, London, United Kingdom B W
    Circulation 128:1325-34. 2013
    ..However, it remains uncertain whether these parameters predict the risks of macrovascular and microvascular complications in patients with type 2 diabetes mellitus...
  28. doi request reprint Effects of fibrates in kidney disease: a systematic review and meta-analysis
    Min Jun
    George Institute For Global Health, The University of Sydney, Sydney, New South Wales, Australia
    J Am Coll Cardiol 60:2061-71. 2012
    ..The purpose of this systematic review and meta-analysis was to determine the efficacy and safety of fibrate therapy in the chronic kidney disease (CKD) population...
  29. doi request reprint Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy
    Sophia Zoungas
    University of Sydney, Sydney, Australia
    Ann Intern Med 151:631-8. 2009
    ..Intravenous sodium bicarbonate has been proposed to reduce the risk for contrast-induced nephropathy (CIN)...
  30. doi request reprint Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial
    John Chalmers
    The George Institute for Global Health, PO Box M201, Camperdown, NSW 2050, Australia
    Hypertension 63:259-64. 2014
    ..38). There was no detectable increase in adverse effects in those receiving CCB. The combination of perindopril and indapamide with CCBs seems to provide further protection against mortality in patients with type 2 diabetes mellitus. ..
  31. pmc The relationship between proteinuria and coronary risk: a systematic review and meta-analysis
    Vlado Perkovic
    The George Institute for International Health, Sydney, New South Wales, Australia
    PLoS Med 5:e207. 2008
    ..We therefore undertook a systematic review of published cohort studies aiming to provide a reliable estimate of the strength of association between proteinuria and coronary heart disease...
  32. doi request reprint Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study
    Yufang Bi
    The George Institute for International Health, Sydney, Australia
    Am Heart J 157:509-516.e1. 2009
    ..Although there is strong evidence for the use of antiplatelet, blood pressure-lowering, and lipid-lowering therapy in patients with acute coronary syndromes, the extent to which these medications are used in China remains uncertain...
  33. ncbi request reprint Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit
    David Peiris
    The George Institute for International Health, PO Box M201 Missenden Rd NSW 2050, Sydney, Australia
    N Z Med J 121:35-46. 2008
    ..To examine the cardiovascular disease (CVD) risk profile and management for the first 12 months of an electronic risk assessment program at Tamaki Healthcare, Auckland...
  34. doi request reprint Global randomized trials: the promise of India and China
    Vlado Perkovic
    The George Institute for Global Health, PO Box M201, Missenden Road, Sydney 2050, Australia
    J Bone Joint Surg Am 94:92-6. 2012
    ..Challenges in both countries are substantial but are able to be managed with appropriate planning...
  35. doi request reprint Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
    Min Jun
    The George Institute for International Health, University of Sydney, Sydney, Australia
    Lancet 375:1875-84. 2010
    ..Several clinical trials have reported inconsistent findings for the effect of fibrates on cardiovascular risk. We undertook a systematic review and meta-analysis to investigate the effects of fibrates on major clinical outcomes...
  36. pmc Comparison of near-patient capillary glucose measurement and a risk assessment questionnaire in screening for type 2 diabetes in a high-risk population in rural India
    Georgia E Ritchie
    The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia
    Diabetes Care 34:44-9. 2011
    ..To assess the utility of a point-of-care (POC) capillary blood glucose measurement as compared with routine clinical parameters in predicting undiagnosed diabetes in a low-resource rural India setting...
  37. doi request reprint Clinical pathways for acute coronary syndromes in China: protocol for a hospital quality improvement initiative
    Ye Rong
    George Institute For Global Health, The University of Sydney, Missenden Road, Sydney, Australia
    Crit Pathw Cardiol 9:134-9. 2010
    ....
  38. doi request reprint Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration
    Ruth Webster
    The George Institute for Global Health, University of Sydney, Sydney, Australia Electronic address
    Int J Cardiol 170:30-5. 2013
    ....
  39. ncbi request reprint A randomised trial of the effects of an additional communication strategy on recruitment into a large-scale, multi-centre trial
    Helen Monaghan
    The George Institute for International Health, University of Sydney, PO Box M201, Missenden Road, Sydney, NSW 2050, Australia
    Contemp Clin Trials 28:1-5. 2007
    ..4 months vs. 5.8 months, p=0.08). The findings suggest that the additional communication strategy may be of some incremental benefit in helping sites achieve recruitment targets sooner...
  40. doi request reprint Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: A cluster randomized controlled trial
    Sanjyot Vagholkar
    General Practice Unit, South Western Sydney Local Health District, Sydney, Australia School of Public Health and Community Medicine, UNSW Medicine, University of New South Wales, Sydney, Australia Electronic address
    Am Heart J 167:28-35. 2014
    ..This randomized controlled trial investigated the impact of CVAR assessment in family practice on management of cardiovascular risk, including prescription of antihypertensive and lipid-lowering medication...
  41. ncbi request reprint Associations of inflammatory and hemostatic variables with the risk of recurrent stroke
    Mark Woodward
    George Institute for International Health, University of Sydney, Australia
    Stroke 36:2143-7. 2005
    ..Little has been published on the associations of these variables with recurrent stroke. We studied such associations in a nested case-control study derived from the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)...
  42. doi request reprint Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies
    Sophia Zoungas
    Diabetes Research Program, Cardiovascular Division, The George Institute for International Health, University of Sydney, Missenden Road, NSW 2050, Australia
    Ann N Y Acad Sci 1212:29-40. 2010
    ..The role of antiplatelet agents remains unknown, as adequately powered trials of aspirin for the primary prevention of cardiovascular events in patients with diabetes have not yet been completed...
  43. doi request reprint New tools for an old trade: a socio-technical appraisal of how electronic decision support is used by primary care practitioners
    David Peiris
    The George Institute for Global Health, Sydney, New South Wales, Australia
    Sociol Health Illn 33:1002-18. 2011
    ..While EDS tools show promise in improving health practitioner performance, the socio-technical dimensions of their implementation warrant careful consideration...
  44. pmc Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular risk
    Hueiming Liu
    The George Institute for International Health, PO Box M201, Missenden Road, NSW 2050, Australia
    BMC Public Health 10:458. 2010
    ....
  45. doi request reprint Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region
    Mark Woodward
    The George Institute for International Health, University of Sydney, Australia
    Eur J Cardiovasc Prev Rehabil 15:397-401. 2008
    ..About half of the world's cases of cardiovascular disease occur in the Asia-Pacific region. The contribution of serum total cholesterol (TC) to this burden is poorly quantified...
  46. pmc Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
    Toshiharu Ninomiya
    George Institute for International Health, University of Sydney, Sydney, NSW, Australia
    J Am Soc Nephrol 20:1813-21. 2009
    ..In conclusion, high albuminuria and low eGFR are independent risk factors for cardiovascular and renal events among patients with type 2 diabetes...
  47. ncbi request reprint Serum lipid levels and the prevalence of dyslipidaemia among rural and urban Thai adults--are the NCEP III guidelines appropriate?
    Anushka Patel
    George Institute for International Health, University of Sydney, Australia
    J Med Assoc Thai 88:1242-50. 2005
    ..Urgent strategies are required to prevent increasing levels of dyslipidaemia in Thailand, as well as to develop and promulgate treatment guidelines that incorporate locally-relevant risk prediction functions...
  48. pmc How important is diabetes as a risk factor for cardiovascular and other diseases in older adults?
    Andre Pascal Kengne
    The George Institute for International Health, The University of Sydney, Sydney, New South Wales, Australia
    PLoS Med 3:e424. 2006
  49. doi request reprint Prevention of cardiovascular disease in a rural region of India and strategies to address the unmet need
    Anna Wood
    The George Institute for Global Health, Sydney, Australia
    Heart 97:1373-8. 2011
    ..To determine levels of cardiovascular disease (CVD) prevention and to model the potential impact of improved prevention strategies for a large rural Indian region...
  50. ncbi request reprint Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region
    Mark Woodward
    Eur Heart J 28:2653-60. 2007
    ..The inverse relationship between high-density lipoprotein (HDL) cholesterol and coronary heart disease (CHD) is well established. Questions remain about the association between HDL cholesterol and stroke, particularly for stroke subtypes...
  51. doi request reprint TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol
    Abdul Salam
    The George Institute for Global Health, Hyderabad, India The George Institute for Global Health, Sydney, Australia School of Public Health, The University of Sydney, Sydney, Australia
    Am Heart J 167:127-32. 2014
    ..The TRIUMPH study aims to investigate the effectiveness, cost-effectiveness, and acceptability of early use of a 3-in-1 BP-lowering pill ("Triple Pill") compared with usual care for the management of hypertension...
  52. doi request reprint Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication compliance
    Kharis Burns
    The George Institute for Global Health, University of Sydney, Camperdown, NSW, Australia
    Int J Pharm Pract 20:155-63. 2012
    ..The objective was to identify the main perceived barriers to compliance and to investigate pharmacists' opinions regarding the routine use of a cardiovascular polypill...
  53. ncbi request reprint Does sex matter in the associations between classic risk factors and fatal coronary heart disease in populations from the Asia-Pacific region?
    Rachel Huxley
    The George Institute for International Health, University of Sydney, NSW, Australia
    J Womens Health (Larchmt) 14:820-8. 2005
    ..Previous comparative studies have generally had insufficient numbers of women to quantify such differences reliably...
  54. pmc Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis
    Philip M Clarke
    School of Public Health, University of Sydney, Sydney, Australia
    PLoS Med 7:e1000236. 2010
    ..Our objective was to estimate and compare event rates, hospital utilization, and costs associated with major diabetes-related complications in high-, middle-, and low-income countries...
  55. ncbi request reprint Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease
    Anushka Patel
    The George Institute for International Health, University of Sydney, PO Box M201, Missenden Road, Sydney, NSW 2050, Australia
    Eur Heart J 26:1910-5. 2005
    ..To evaluate the role of plasma lipids in recurrent vascular events, including stroke, among individuals with established cerebrovascular disease...
  56. doi request reprint Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice
    Qing Wan
    Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia
    Am Heart J 157:436-41. 2009
    ..This study aims to investigate both the feasibility of using this model and the impact of CVAR assessment and management on general practice clinical processes and patient care...
  57. ncbi request reprint Diabetes and vascular disease: a new international trial
    Anushka Patel
    International Coordinating Centre for ADVANCE, Institute for International Health, University of Sydney, PO Box 576, Newtown, New South Wales 2042, Australia
    Asian Cardiovasc Thorac Ann 11:180-4. 2003
    ..This study is the first large-scale randomized trial in diabetes to include participants from both lower- and higher-income regions of the world...
  58. ncbi request reprint Validation of a general practice audit and data extraction tool
    David Peiris
    MBBS, MIPH, PhD, FRACGP, FARGP, Head of Primary Health Care Research, The George Institute for Global Health, University of Sydney, Camperdown, New South Wales
    Aust Fam Physician 42:816-9. 2013
    ..We assessed how accurately a common general practitioner (GP) audit tool extracts data from two software systems...
  59. ncbi request reprint The role of the 12-lead ECG as a screening test for cardiac source of embolus
    Clara Kayei Chow
    Department of Cardiology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia
    Heart Lung Circ 14:242-4. 2005
    ..We sort to investigate whether 12-lead ECG might be useful in screening patients to obviate the need for TTE, in a subset of patients referred for echocardiographic investigation of cardiac source of embolus...
  60. ncbi request reprint Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease
    Duncan J Campbell
    St Vincent s Institute of Medical Research, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia
    Hypertension 45:69-74. 2005
    ..Moreover, NT-proBNP and CRP may be markers of mechanisms of CHF pathogenesis distinct from those responsive to angiotensin-converting enzyme inhibitor-based therapy...
  61. ncbi request reprint Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease
    Duncan J Campbell
    St Vincent s Institute of Medical Research, Fitzroy, Victoria, Australia
    J Hypertens 25:699-705. 2007
    ..Active treatment reduced cardiovascular events, and we therefore investigated whether active treatment modified NT-proBNP and other cardiovascular risk factors...
  62. doi request reprint Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    Anushka Patel
    N Engl J Med 358:2560-72. 2008
    ..In patients with type 2 diabetes, the effects of intensive glucose control on vascular outcomes remain uncertain...
  63. ncbi request reprint Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease
    Duncan J Campbell
    St Vincent s Institute of Medical Research, Fitzroy, Victoria, Australia
    Eur J Cardiovasc Prev Rehabil 14:413-8. 2007
    ..Only limited data are available for risk factors for intracerebral haemorrhage (ICH) in subjects with established cerebrovascular disease...
  64. ncbi request reprint Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus
    Ronald P Stolk
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
    Contemp Clin Trials 28:6-17. 2007
    ....
  65. ncbi request reprint Acupuncture for blood pressure lowering: needling the truth
    Fiona Turnbull
    Circulation 115:3048-9. 2007
  66. doi request reprint Why is there more heat than light concerning the polypill?
    Anthony Rodgers
    BMJ 337:a2162. 2008
  67. doi request reprint Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: baseline results from the ADVANCE Retinal Measurements (AdRem) study
    Ronald P Stolk
    Department of Epidemiology, University Medical Center Groningen, P O Box 30 001, 9700RB Groningen, The Netherlands
    Diabetes Care 31:708-13. 2008
    ....
  68. ncbi request reprint Body mass index and risk of diabetes mellitus in the Asia-Pacific region
    Cliona Ni Mhurchu
    Asia Pac J Clin Nutr 15:127-33. 2006
    ..The results indicate considerable potential for reduction in incidence of diabetes with population-wide lowering of body mass index in this region...